Events

Braintech 2017 : March 6-7, Tel-Aviv Israel

Marc 6-7, 2017

 

 

ADPD – Vienna – Austria - Dr. Babak Tousi - EFFECTS OF A COMBINED TRANSCRANIAL MAGNETIC STIMULATION (TMS) AND COGNITIVE TRAINING IN ALZHEIMER PATIENTS: SAFETY RESULTS OF MEDICAL DEVICE PIVOTAL MULTI-CENTER STUDY

 

March 29th – April 2nd 2017

 

 

2017 ARIZONA ALZHEIMER’S CONFERENCE SCIENTIFIC CONFERENCE

May 18, 2017

 

 

NeuroTech Conference – San Francisco

Eyal Baror will speech in this conference - Wednesday, May 31 10:40 - Treatments for Alzheimer's and Cognitive Disorders
Globally, the population continues to age and the number of dementia patients keeps expanding. Ongoing efforts to develop disease modifying therapies have been plagued with failures. What new avenues are being pursued to address the growing global need? Will novel diagnostics allow us to initiate treatments earlier? What non-pharmacological options are in development?
Panelists: Casey Lynch, CEO, Cortexyme
Mark Gurney, CEO, Tetra Discovery Partners
Eyal Baror, CEO and President, Neuronix

31st May – 1st June 2017

 

 

Past Events

 

CTAD conference in San Diego December 8-10.2016

December 8-10, 2016

neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.



® January 12, 2017 Neuronix | All rights reserved.